Henry Chrystyn

9.5k total citations · 1 hit paper
190 papers, 7.0k citations indexed

About

Henry Chrystyn is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Animal Science and Zoology. According to data from OpenAlex, Henry Chrystyn has authored 190 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 143 papers in Pulmonary and Respiratory Medicine, 106 papers in Physiology and 22 papers in Animal Science and Zoology. Recurrent topics in Henry Chrystyn's work include Inhalation and Respiratory Drug Delivery (130 papers), Asthma and respiratory diseases (105 papers) and Respiratory and Cough-Related Research (31 papers). Henry Chrystyn is often cited by papers focused on Inhalation and Respiratory Drug Delivery (130 papers), Asthma and respiratory diseases (105 papers) and Respiratory and Cough-Related Research (31 papers). Henry Chrystyn collaborates with scholars based in United Kingdom, United States and Netherlands. Henry Chrystyn's co-authors include David Price, Michael Hindle, K.H. Assi, Sinthia Bosnic‐Anticevich, Mohamed E. A. Abdelrahim, Walid Tarsin, Brian J. Clark, John Haughney, Stanley B. Pearson and Sarah Corlett and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, CHEST Journal and European Respiratory Journal.

In The Last Decade

Henry Chrystyn

188 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

What the pulmonary specialist should know about the new inhalation therapies

2011 584 citations Henry Chrystyn et al. European Respiratory Journal profile →

Peers

Countries citing papers authored by Henry Chrystyn

Since Specialization

Citations

This map shows the geographic impact of Henry Chrystyn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry Chrystyn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry Chrystyn more than expected).

Fields of papers citing papers by Henry Chrystyn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry Chrystyn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry Chrystyn. The network helps show where Henry Chrystyn may publish in the future.

Co-authorship network of co-authors of Henry Chrystyn

This figure shows the co-authorship network connecting the top 25 collaborators of Henry Chrystyn. A scholar is included among the top collaborators of Henry Chrystyn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henry Chrystyn. Henry Chrystyn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dry Powder Inhalers: From Bench to Bedside 2023 ·Journal of Aerosol Medicine and Pulmonary Drug Delivery ·Henry Chrystyn, (unknown), Walid Tarsin	4
2	Evaluation of inhaler technique and achievement and maintenance of mastery of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in adult patients with asthma: the Easy Low Instruction Over Time (ELIOT) study 2018 ·BMC Pulmonary Medicine ·David Price, Vicky Thomas, P. N. Richard Dekhuijzen, Sinthia Bosnic‐Anticevich, Nicolás Roche, Federico Lavorini, (unknown), Daryl Freeman, (unknown), Iain Small, Erika Sims, Guilherme Safioti, Janice Canvin, Henry Chrystyn	9
3	Inhalation characteristics with Spiromax® (S) versus Turbuhaler® (T) dry powder inhalers (DPI) in healthy adults (HA) and in patients with asthma (A) or COPD 2013 ·European Respiratory Journal ·(unknown), Philip Chetcuti, Harold Hosker, Dinesh Saralaya, Henry Chrystyn	3
4	Effectiveness of Inhaler Devices in Adult Asthma and COPD 2013 ·Nicolás Roche, Henry Chrystyn, Federico Lavorini, Àlvar Agustí, J. Christian Virchow, Richard Dekhuijzen, David Price	20
5	Real-life inhalation therapy – inhaler performance and patient education matter 2012 ·University of Huddersfield Repository (University of Huddersfield) ·Henry Chrystyn, (unknown)	6
6	Mandibular advancement achieved through a stepped mouthpiece design can change the size of the upper airways. 2010 ·University of Huddersfield Repository (University of Huddersfield) ·Kurt Nikander, (unknown), (unknown), (unknown), (unknown), Henry Chrystyn	1
7	In vitro characterization of the emitted dose from the foradil aerolizer to identify the influence of inhalation flow, inhilation volume and the number of inhalations per dose 2010 ·University of Huddersfield Repository (University of Huddersfield) ·(unknown), K.H. Assi, Henry Chrystyn	4
8	Evaluation of supercritical fluid engineered budesonide powder for respiratory delivery using nebulisers 2009 ·Journal of Pharmacy and Pharmacology ·Amir Amani, Henry Chrystyn, Brian J. Clark, Mohamed E. A. Abdelrahim, Peter York	11
9	Evaluation of supercritical fluid engineered budesonide powder for respiratory delivery using nebulisers 2009 ·Journal of Pharmacy and Pharmacology ·Amir Amani, Henry Chrystyn, Brian J. Clark, Mohamed E. A. Abdelrahim, Peter York	2
10	Aerodynamic Characteristics of Nebulized Terbutaline Sulphate Using the Next Generation Impactor (NGI) and CEN Method 2009 ·Journal of Aerosol Medicine and Pulmonary Drug Delivery ·Mohamed E. A. Abdelrahim, Henry Chrystyn	42
11	Salbutamol relative lung and systemic bioavailability of large and small spacers 2008 ·Journal of Pharmacy and Pharmacology ·(unknown), Henry Chrystyn	16
12	Salbutamol relative lung and systemic bioavailability of large and small spacers 2008 ·Journal of Pharmacy and Pharmacology ·(unknown), Henry Chrystyn	12
13	Pharmaceutical Technology 2007 ·Journal of Pharmacy and Pharmacology ·(unknown), Anant Paradkar, Kakasaheb Mahadik, Sachin Kadam, Mohamed E. A. Abdelrahim, Mostafa M. Ghorab, Ahmed Abdelbary, Marina Levina, Huy Gia Vuong, Deborah Palmer, (unknown), K.H. Assi, Henry Chrystyn, Yousef Javadzadeh, (unknown), (unknown), Ali Nokhodchi	22
14	Relative lung deposition of salbutamol following inhalation from a spacer and a Sidestream jet nebulizer following an acute exacerbation 2007 ·British Journal of Clinical Pharmacology ·(unknown), Nahlah Elkudssiah Ismail, Duncan Newton, Henry Chrystyn	30
15	A Logistic Regression Analysis of Predictors for Asthma Hospital Re-admissions 2003 ·Iranian journal of pharmaceutical research ·Jamshid Salamzadeh, Ian Chi Kei Wong, (unknown), Henry Chrystyn	2
16	Dry Powder versus Intravenous and Nebulized Gentamicin in Cystic Fibrosis and Bronchiectasis: A Pilot Study 1999 ·American Journal of Respiratory and Critical Care Medicine ·N. R. Labiris, Anne Holbrook, Henry Chrystyn, Stuart MacLeod, Michael T. Newhouse	61
17	Relative Bioavailability of Salbutamol to the Lung Following Inhalation via Two Versions of a Novel Dry Powder Inhaler (Clickhaler) and a Standard Pressurized Metered Dose Inhaler (Ventolin) 1998 ·Pharmacy and Pharmacology Communications ·(unknown), Mark Parry‐Billings, Henry Chrystyn	5
18	Evaluation of In‐vivo Lung Deposition Following Inhalation from a Rotahaler and Cyclohaler Using Urinary Salbutamol Excretion 1996 ·Pharmacy and Pharmacology Communications ·(unknown), Henry Chrystyn	4
19	Response to oral theophylline in severe chronic obstructive airways disease: Authors' reply 1989 ·BMJ ·M. Peake, Henry Chrystyn, B A Mulley	4
20	Dose response relation to oral theophylline in severe chronic obstructive airways disease. 1988 ·BMJ ·Henry Chrystyn, B A Mulley, M. Peake	114

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact